Press Release | May 28, 2024
Affini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Read More
Video | May 6, 2024
BIOSECURE Act Discussion featuring Cartier Esham, Ph.D. of BIO
Read More
Press Release | April 2, 2024
Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer
Read More
News | March 25, 2024
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
Read More
